Overall Economic Summary
The dominant macro narrative this morning is the 2026 Strait of Hormuz crisis. Iran has tightened control over the world’s most critical oil chokepoint after the US called off renewed military strikes, and Brent crude has crossed $102/barrel while WTI sits above $93 — the International Energy Agency has characterized this as the largest supply disruption in the history of the global oil market. The ceasefire framework that briefly calmed markets last week is back in question, and every equity rally is now subject to sudden reversal risk whenever a new headline lands from the Gulf.
Against that backdrop, the earnings season is delivering a structurally bullish read: 81% of the 87 S&P 500 companies reporting have beaten EPS, and 76% have topped revenue forecasts. The problem is guidance — companies referencing geopolitical uncertainty as a reason to hold rather than raise full-year outlooks (IBM, HON) are getting sold hard. ServiceNow’s sequential margin decline and Tesla’s $20-25B capex shock are today’s primary single-stock stories, both carrying wider sector implications for high-growth software and EV/AI infrastructure spend respectively.
The week ahead concentrates risk: Q1 GDP Advance Estimate prints April 30, and any reading below the 2% trend will amplify oil-inflation anxieties. AI infrastructure demand narratives remain intact — Micron’s 2026 HBM production is sold out, TSM reported $35.9B in Q1 revenue on 30%+ 2026 growth guidance, and Google’s Cloud AI push is accelerating enterprise adoption. The structural bull case for technology and innovation is alive; execution risk around capex cycles and geopolitical uncertainty is the near-term drag.
Today’s Earnings
Cons. EPS: $2.32 · Reported: $2.45 (Beat +5.6%) · Revenue: $9.14B vs $9.2B est (Miss)
Watch for the gap-down open despite the EPS beat — the market is punishing any revenue miss in this environment. Honeywell’s Q2 profit guidance came in below estimates, with management citing Middle East war disruptions and geopolitical uncertainty. With the company recently splitting off its aerospace business, clarity on the industrial automation and building-tech segments will drive post-open price action.
Cons. EPS: $4.06 · Reported: $4.28 (Beat +5.4%) · Revenue: $18.91B vs $18.80B est (Beat)
Clean beat across the board with full-year guidance maintained. Platinum card spending holding up well despite the macro backdrop — watch for a gap-up open that holds or fades into the broader market slippage. Strong Millennial/Gen-Z card adoption cited as a key growth driver.
Cons. EPS: ~est · Revenue: Beat
Comcast beat on both Q1 earnings and revenue, sending shares climbing pre-market. Despite ongoing cord-cutting pressure, the company’s broadband and streaming segments are offsetting linear TV declines. Watch CMCSA for a momentum continuation trade if it gaps up clean above the prior resistance level.
Cons. EPS: ~est · Revenue: Miss on both metrics
Lockheed missed both EPS and revenue expectations, a surprise given the elevated geopolitical environment and expected defense spending tailwinds from the US-Iran conflict. Watch for a morning gap fill trade — the sector narrative (increased defense budgets) is still bullish medium-term, so a gap-down opening may attract dip buyers by mid-session.
Cons. EPS: ~est · Sequential margin decline reported
ServiceNow fell approximately 12% in after-hours after reporting a sequential decline in profit margins and subscription revenue headwinds. The stock hit an intraday low of $87 before recovering toward $90-103 on April 23. This is the primary morning short candidate — watch the $87 level as ultimate support and $103-105 as the key resistance zone. Software names showing margin compression will remain under pressure.
Cons. EPS: $1.81 · Reported: $1.91 (Beat) · Revenue: $15.92B vs $15.62B est (Beat) · Guidance maintained
IBM beat on both metrics yet shares fell 6-7% after-hours because guidance was maintained rather than raised. CEO Arvind Krishna explicitly flagged geopolitical uncertainty as a headwind. The market is pricing in a stagflation scenario where even a strong Q1 doesn’t merit 2026 upside revision. Watch for capitulation or a bounce at the 200-day MA.
Revenue: $22.4B · Deliveries: 358,023 (vs 372K est, −4% miss) · Capex: $20-25B 2026 guidance
Tesla’s “spending shock” is dominating the morning narrative. Musk confirmed plans to substantially increase capital investments in 2026 — $20-25B including Cybercab, Optimus robotics, Terafab AI compute, and chip development — compared to just ~$9B in 2025. Revenue of $22.4B came in above estimates but delivery miss plus free cash flow compression is weighing on shares. Watch the energy storage division, which saw revenue fall 15% YoY. Dan Ives (Wedbush) reiterated bullish view, saying Tesla is now more AI company than car company.
Key Events Today
🛢 US-Iran Strait of Hormuz — Ceasefire Status
All Day | Geopolitical Risk Factor
Iran has tightened control over the Strait of Hormuz after the US called off renewed strikes. The IEA has called this the largest oil supply disruption in history. Brent is above $102, WTI above $93. Every geopolitical headline today carries market-moving potential — monitor CNBC and Reuters live desks from the market open.
📊 S&P Global Flash PMIs — Manufacturing & Services
9:45 AM ET | High Impact
April preliminary PMI prints are the primary scheduled economic risk today. Manufacturing consensus is around 49.5 (contraction territory). A weaker-than-expected print will amplify concerns that oil-driven supply chain disruptions are hitting factory activity. Services PMI at ~53.5 is the growth anchor — a miss there could accelerate the morning selloff.
📦 Q1 2026 Earnings Season — Peak Week
All Day | Reporting Season Continues
We are in the peak week of Q1 2026 earnings season with 87 S&P 500 companies having reported (81% beat rate). Today adds HON, AXP, CMCSA, and LMT to the scorecard. After the close, watch for any major tech names (Alphabet guidance range includes April 23-29). The mixed guidance environment from IBM and ServiceNow is setting a cautious tone for software sector outlooks.
🤖 Tesla “Terafab” AI Compute Facility
All Day | Thematic Event
Tesla confirmed its Terafab one-terawatt AI compute facility project is moving forward and was explicitly excluded from the already-elevated $20-25B 2026 capex guidance. This positions Tesla alongside Meta, Microsoft, and Amazon as a hyperscale AI infrastructure spender, and will likely draw analyst upgrades in the AI infrastructure theme. Watch DELL, ANET, VRT, and data center picks for sympathy.
Top 5 Movers
Regime: NEUTRAL — balanced long and short setups. Stock-specific catalysts prioritized. Filtering preferred and acceptable sectors first.
High-growth Software · Pre-mkt Vol: ~est high · ATR: ~$15–18 ~est · Float: ~200M shares ~est · Rel. Vol: ~est 5×+
Catalyst
Q1 2026 earnings (reported after close April 22) revealed a sequential decline in profit margins and subscription revenue headwinds. The stock gapped from ~$103 close to $90.43 pre-market — a gap of 12.33%. MarketBeat confirms NOW is trading lower after reporting quarterly results.
Why It’s Moving
The market is in “guide or die” mode. ServiceNow beat on some metrics but the sequential margin compression signal suggests cost pressures and/or slowing enterprise renewal cycles. In a regime where IBM — which beat EPS — dropped 7% for not raising guidance, a name showing actual margin deterioration gets no mercy. Institutional unwinding is the dominant flow.
Key Daily Price Levels
Pre-market consolidation range: $87.00–$90.43. Watch for VWAP anchor to set near $90–92 at open. The $87.00 intraday low is the critical downside level — a break there opens a move toward $80–83 (prior consolidation base). 20-day MA ~est $108; 50-day MA ~est $104; 200-day MA ~est $95. ATR(14) ~$15–18 ~est. Bias: SHORT. Look for opening range breakdown below $90 for continuation, or fade the bounce into $103–105 resistance.
Support & Resistance
Support: $87.00 (intraday low / key technical), $80–83 (prior consolidation base ~est). Resistance: $90.43 (pre-market open), $103–105 (prior close / gap fill), $108 (20-day MA ~est).
Sources: MarketBeat earnings report, CNBC video “IBM and ServiceNow both trading lower,” Sherwood News “ServiceNow dives after sequential decline,” Bloomberg search results
Biotech / Hard Catalyst · Pre-mkt Vol: ~est high (multi-day catalyst) · ATR: ~$8–12 ~est · Float: ~est 40–60M shares
Catalyst
Inhibrx announced preliminary Phase 1/2 data for ozekibart (INBRX-109) in advanced colorectal cancer: 40% Objective Response Rate versus just 1–6% historical standard of care, 87% disease control rate, 5.5-month median PFS. Simultaneously, the company submitted a BLA to the FDA for ozekibart in conventional chondrosarcoma (rare bone cancer). Large drugmakers are now reported to be eyeing Inhibrx assets at a valuation above $8 billion. A $150 price target was issued April 22. The stock surged 36% on April 22, closing at $114.44 after reaching a high of $155.29 intraday.
Why It’s Moving
This is a multi-catalyst biotech event — clinical data showing dramatic superiority over SoC plus an M&A premium being priced in. The buyout interest from large drugmakers adds a floor to the stock, and the BLA submission in chondrosarcoma is a near-term binary catalyst. The momentum is driven by retail positioning on Stocktwits combined with institutional FOMO on the acquisition angle.
Key Daily Price Levels
Previous close: $114.44. Pre-market ~$114–125 ~est. VWAP anchor will be critical — watch whether price holds above $114.44 (yesterday’s close) for continuation. The $155.29 intraday high from April 22 is the next target if momentum resumes. Bias: LONG (momentum continuation). Look for a clean hold above $114 at open with volume confirmation. Risk management: tight stop below $105 (prior day VWAP ~est). ATR(14) ~$10 ~est.
Support & Resistance
Support: $105 (intraday VWAP ~est), $87 (prior consolidation mid-$80s), $114.44 (prior close, now support). Resistance: $130 (round number), $155.29 (April 22 high), $160 (analyst target zone).
Wyckoff Phase
Mark-up Phase — strong volume surge on catalyst with institutional interest. Watch for distribution signals at the prior intraday high ($155) if the stock gets there.
Sources: BioSpace Phase 1/2 data release, Inhibrx ozekibart BLA FDA submission, Benzinga “Drugmakers eye Inhibrx cancer drugs valued over $8B,” TimothySykes.com INBX $150 target, StockTitan regulatory filing
Enterprise Technology · Pre-mkt Vol: ~est elevated · ATR: ~$6–9 ~est · Float: ~900M shares · Rel. Vol: ~2–3× ~est
Catalyst
IBM reported Q1 2026 earnings after close April 22: EPS $1.91 vs $1.81 expected (beat), revenue $15.92B vs $15.62B expected (beat). Revenue grew 9% YoY. Despite the clean beat, shares fell 6–7% because full-year guidance was maintained — not raised — and CEO Arvind Krishna explicitly cited “geopolitical uncertainty” from the Iran conflict as a reason for caution.
Why It’s Moving
This is the epitome of “sell the guidance hold” in the current environment. When every stock is at record highs and the market expects beats to come with upside guidance revisions, a flat guidance reiteration reads as a downgrade. IBM’s watsonx AI platform is showing traction but the market is pricing in macro headwinds dampening enterprise software deals. The stock is being used as a proxy short for “slow AI adoption” thesis.
Key Daily Price Levels
Pre-market ~$234–240 ~est from prior close ~$252. Key VWAP anchor will form near the open. 200-day MA ~est $228–232 is the critical support level. If the gap fills back toward $245–248, that’s the first resistance. Bias: SHORT on gap opens below $244. Watch for dead-cat bounce into $244–248 (gap-fill zone) as a short entry. Cover near $228 (200-day MA ~est). ATR(14) ~$7 ~est.
Support & Resistance
Support: $228–232 (200-day MA ~est), $220 (prior structure support ~est). Resistance: $244–248 (gap-fill zone), $252 (prior close), $260 (50-day MA ~est).
Sources: CNBC IBM Q1 earnings report, Benzinga “IBM Shares Drop Despite Q1 Earnings Beat,” InsiderFinance IBM Q1 2026 recap, Motley Fool Breakfast News “IBM Hit by Inflation’s Long Shadow”
EV / AI Innovation (STRONGLY PREFERRED) · Pre-mkt Vol: 1.05M shares (confirmed) · ATR: ~$15–20 ~est · Float: ~3.2B shares · Rel. Vol: ~1.5× ~est
Catalyst
Tesla’s Q1 2026 results (AMC April 22) delivered a “spending shock”: 2026 capex guidance of $20-25B (compared to ~$9B in 2025) covering Cybercab production, Optimus robots, AI compute, and chipmaking. Terafab — a planned one-terawatt AI compute facility — was explicitly excluded from the $20-25B figure, implying even more spending. Deliveries came in at 358,023 vs 372,160 estimated (−4% miss). Energy storage revenue fell 15% YoY. Revenue of $22.4B beat.
Why It’s Moving
Free cash flow compression from capex explosion is the core concern. While bulls (Dan Ives: “Tesla is now more AI company than car company”) see the spending as transformational, the near-term read is simple: $25B+ cash out the door in 2026 vs $9B last year destroys free cash flow for multiple quarters. The EV core business is also under pressure with delivery miss and energy storage weakness. The gap may be limited today as the AI pivot narrative absorbs some selling.
Key Daily Price Levels
Pre-market range: $375.60–$388 ~est. Prior close ~$390 ~est. VWAP at open will anchor the first 30 minutes. Key levels: $375–376 (pre-market low), $390 (prior close / gap resistance). Bias: SHORT if gap is ≥2% at open and price stays below VWAP. Watch for momentum continuation if pre-market gap widens. Gap may be below 2% threshold — confirm at open before entering. ATR(14) ~$18 ~est.
Support & Resistance
Support: $375–376 (pre-market low), $360 (prior structure ~est), $340 (50-day MA ~est). Resistance: $388–390 (gap-fill zone / prior close), $400 (round number), $420 (52-week high area ~est).
Sources: Bloomberg Tesla Q1 earnings live blog, CNBC Dan Ives video, Yahoo Finance Tesla Q1 preview, CNBC Morning Squawk “Tesla’s spending shock”
Industrials / Building Tech & Aerospace (ACCEPTABLE) · Pre-mkt Vol: ~est elevated (BMO earnings) · ATR: ~$4–6 ~est · Float: ~650M shares ~est
Catalyst
Honeywell reported Q1 2026 earnings before market open today: EPS $2.45 vs $2.32 expected (beat, +5.6%), but revenue of $9.14B missed the $9.2B estimate (miss). Full-year revenue guidance of $39.3B midpoint came in 0.5% below analyst estimates. Q2 profit guidance also disappointed, with management citing Middle East war disruptions. Search result confirms: “Honeywell (NASDAQ:HON) Misses Q1 CY2026 Sales Expectations, Stock Drops.”
Why It’s Moving
The revenue miss on a BMO earnings day is particularly damaging because there’s no overnight recovery time — the reaction prints at the open immediately. Honeywell’s building automation and safety products are directly exposed to Middle East construction and energy infrastructure spending, so the geopolitical risk angle is real, not just a management talking point. The recent spin-off of HON’s aerospace segment has also reduced the “defense tailwind” buffer that historically protected the stock.
Key Daily Price Levels
Prior close ~$220 ~est (needs verification at open). Pre-market gap -5%+ implies open around ~$209. VWAP will form within first 15 minutes of the open. Bias: SHORT on gap continuation below VWAP. Key support at 52-week lows ~est $195–200. Resistance at the pre-market high / prior close. ATR(14) ~$5 ~est.
Support & Resistance
Support: $200 (round number / 52-week low ~est), $195 (prior structure ~est). Resistance: Prior close ~$220 ~est (gap-fill), $225 (50-day MA ~est).
Sources: FinancialContent “Honeywell NASDAQ:HON Misses Q1 CY2026 Sales Expectations,” Meyka HON earnings preview, Yahoo Finance Honeywell Q1 earnings
Research Themes
🧠 AI Memory Supercycle — HBM3E / HBM4 Demand Structural Override
Micron’s entire 2026 HBM production capacity is sold out. Pricing and volume agreements for both HBM3E and next-gen HBM4 are locked. The company projects the HBM TAM to expand from $35B (2025) to $100B (2028) two years ahead of prior estimates. Micron’s HBM3E uses 30% less power than Samsung — a critical advantage in power-constrained AI data centers. Despite today’s slight pre-market dip (−1.47%), the structural demand case is unbroken. Any meaningful pullback in MU, SNDK, or ARM is a long-term buying opportunity in the AI compute buildout. TSM’s Q1 2026 revenue hit $35.9B on 30%+ 2026 growth guidance — the entire semiconductor food chain is benefiting.
Tickers: MU, NVDA, SNDK, TSM, ARM, MRVL, ONTO
Sources: FinancialContent Micron HBM Deep Dive 2026, Alpha Spread “Micron Rallies as AI Demand Sells Out 2026 HBM,” TSM April 22 earnings, BofA $1T chip surge 2026 note
⚛️ Nuclear & Energy Security Renaissance — Oil Above $100 Accelerates the Thesis
With Brent at $102 and WTI at $93+, every energy-independent power generation thesis gets a shot of adrenaline. Nuclear is the cleanest expression: OKLO, NNE, SMR, and CEG are direct beneficiaries as utilities rush to lock in long-term baseload power contracts for AI data centers that can’t be exposed to oil-driven electricity cost volatility. The Iran-Hormuz crisis has put energy security on every board’s agenda. Any ceasefire-driven oil pullback is likely temporary — the structural buildout of alternative power remains the multi-year trade. Watch for breakouts in small/mid-cap nuclear names on any sector rotation from energy (XLE) into clean energy infrastructure.
Tickers: OKLO, NNE, SMR, CEG, VST, BWXT, ETN, PWR
Sources: Reuters Morning Bid “Tech checked as oil boils,” Reuters Daily Briefing “Iran tightens control of Hormuz,” Motley Fool “Iran Fired on Ships in the Strait of Hormuz. These Energy Stocks Could Surge”
🔻 Software Guidance Reckoning — The “No Raise = Sell” Regime
ServiceNow (−12%) and IBM (−7%) this morning have established a clear market rule: in Q1 2026, maintaining guidance is treated as a guidance cut. The S&P 500 is at record highs and valuations are stretched — the market needs upside guidance to justify multiples at these levels. Any high-growth software name with even a hint of margin compression or flat forward commentary will be sold aggressively. This creates a trading opportunity on the short side for upcoming software earners (watch CRWD, DDOG, SNOW, ZS), and a long opportunity for any name that genuinely beats AND raises (the setup is less crowded). Institutions are rotating from “hope and multiple expansion” to “show me the margin.”
Watch SHORT: NOW, IBM, GTLB · Watch LONG (beat & raise potential): CRWD, DDOG, ZS
Sources: CNBC video “IBM and ServiceNow both trading lower,” Sherwood News “ServiceNow dives,” IBM Q1 2026 earnings CNBC, Reuters “Wall St futures slip as investors pause”